Max Chan
Chief Operating Officer
LEADERSHIP TEAM
OBI Pharma
Taiwan
Biography
Mr. Chan is a seasoned executive with over 24 years of multinational experience and a long track-record of achievement. He was formerly the CFO of Taiwan-listed JHL Biotech (TPEx: 6540) and TaiGen Biotech (TPEx: 4157) as well as US-listed Himax Technologies (NASDAQ: HIMX). Mr Chan's prior background was that of an investment professional, including stints at Intel Capital and China Development Industry Bank. Mr Chan hold a Masters of Science in Business Administration degree from the University of Illinois at Urbana-Champaign as well as an MBA in Finance and a BS degree in Civil Engineering from National Taiwan University.
Research Interest
Business Administration
